Wei Xiong

7PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMedical mycologyMolecular targetsModelling and simulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 03, 2025
Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss.

Liuling Xiao, Rui Duan, Wendao Liu

|Jan 04, 2025
Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitors.

Wei Xiong, Liuling Xiao, Rui Duan

|Jul 09, 2024
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis.

Miao Xian, Qiang Wang, Liuling Xiao

|Jan 24, 2024
Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers.

Jianfei Qian, Qiang Wang, Liuling Xiao

|Mar 26, 2022
Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy.

Xin Liu, Yixiang Xu, Wei Xiong

|Mar 18, 2022
In vitro machine learning-based CAR T immunological synapse quality measurements correlate with patient clinical outcomes.

Alireza Naghizadeh, Wei-Chung Tsao, Jong Hyun Cho

Pageof 2

Frequent Collaborators

5 joint publications

Qing Yi

3 joint publications

Qiang Wang

2 joint publications

Liuling Xiao

2 joint publications

Miao Xian